SANA
Sana Biotechnology Inc
2.80$
+0.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | +11.0% | +14.7% | +20.3% | +11.4% | -38.9% | +89.3% | +3.5% | +3.5% | +1.9% | -42.7% | +67.6% | -50.3% | +4.0% | +4.2% | +88.3% | -52.2% | -21.7% | – | – | -21.7% | – | – | |
| – | – | – | – | – | -102.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -147.8% | – | – | – | – | – | – | |
| – | -30.4% | +199.8% | -45.6% | +133.7% | +62.3% | -81.6% | +125.6% | +40.9% | -82.5% | +216.6% | +29.4% | -17.3% | +15.1% | +48.2% | -83.0% | +310.7% | +35.3% | -65.1% | +44.9% | -29.6% | +16.5% | +2.2% | -17.0% | +47.5% | -51.0% | +127.5% | – | |
| – | +2.4% | +0.9% | +18.1% | +29.7% | +28.4% | +5.5% | +7.7% | -5.6% | +13.8% | +26.7% | -15.2% | +50.3% | -28.1% | -1.2% | +15.8% | +8.3% | -21.7% | +1.1% | -14.5% | +23.0% | -33.5% | -10.0% | -0.5% | +18.5% | -5.9% | -6.0% | – | |
| – | -26.2% | +164.2% | -41.3% | +119.4% | +59.5% | -110.3% | – | +33.4% | -71.5% | +130.1% | +18.2% | -5.1% | +2.8% | +38.4% | -98.1% | +4,054.9% | +22.2% | -55.4% | +25.1% | -17.6% | -0.5% | +87.6% | -54.2% | +40.6% | -42.0% | +84.4% | – | |
| – | – | – | – | – | – | – | -549.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +7.4% | +21.5% | +69.0% | -11.2% | +168.8% | +84.1% | +54.3% | +6.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -545.7% | – | – | – | – | – | – | – | – | -9,055.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -50.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -545.7% | – | – | – | – | – | – | – | – | -9,055.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -477.6% | – | – | – | – | – | – | – | – | -1,501.7% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.